Bacteria Combination

Product NDC

43742-1587

11-digit product format

437421587

Labeler code

43742

Product ID

43742-1587_e357ad88-3b57-490f-bbc7-b425eb7ba9d7

Type

HUMAN OTC DRUG

Nonproprietary name

Adenosinum Triphosphoricum Dinatrum, Malicum Acidum, Natrum Oxalaceticum, Oroticum Acidum, Riboflavinum, Cinnamic Acid, Petroselinum Sativum, Colibacillinum Cum Natrum Muriaticum, Echinacea (Angustifolia), Helicobacter Pylori, Mycoplasma Pneumoniae, Proteus (Mirabilis), Proteus (Vulgaris), Pseudomonas Aeruginosa, Salmonella Typhi Nosode, Enterococcus Faecalis, Streptococcus Mutans, Pneumococcinum, Streptococcus Agalactiae, Legionella Pneumophila, Listeria Monocytogenes, Dysentery Bacillus, Shigella Sonnei,

Dosage form

LIQUID

Route

ORAL

Labeler

Deseret Biologicals, Inc.

Marketing category

UNAPPROVED HOMEOPATHIC

Marketing start

2019-11-18

Marketing end

2025-07-20

Substance

ADENOSINE PHOSPHATE DISODIUM; MALIC ACID; SODIUM DIETHYL OXALACETATE; OROTIC ACID MONOHYDRATE; RIBOFLAVIN; CINNAMIC ACID; PETROSELINUM CRISPUM; ESCHERICHIA COLI; ECHINACEA ANGUSTIFOLIA; HELICOBACTER PYLORI; MYCOPLASMA PNEUMONIAE; PROTEUS MIRABILIS; PROTEUS VULGARIS; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA ENTERICA SEROVAR TYPHI; ENTEROCOCCUS FAECALIS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS AGALACTIAE; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; STREPTOCOCCUS DYSGALACTIAE; PROTEUS MORGANII; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS UBERIS; STREPTOCOCCUS VIRIDANS GROUP

Active strength

6 [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record